What Could Change After Acrivon Therapeutics Inc (NASDAQ: ACRV) Gains 66.03% From The High-Point?
Acrivon Therapeutics Inc (NASDAQ:ACRV)’s traded shares stood at 0.63 million during the last session, with the company’s beta value hitting 0.80. At the close of